The EPA has withdrawn a 2020 Roundup cancer risk assessment after determining it could not meet a court deadline to reassess the health risks of the popular weed killer.
A new study links Roundup exposure to an increased risk of convulsions in animals.
Plaintiffs say it is time to "wind down" the Roundup MDL, or else face indefinite waves of trials in federal courts.
A Missouri jury has delivered a defense verdict in a recent Roundup non-Hodgkin's lymphoma lawsuit involving multiple plaintiffs.
The EPA says it will be unable to make a court-mandated deadline of October 1 for completing a reassessment of Roundup cancer risks.
A new study finds that Roundup weed killer's active ingredient, glyphosate, passes through the blood-brain barrier, potentially increasing the risk of Alzheimer's and other neurodegenerative diseases.
A new CDC study finds nearly 9-of 10 U.S. children have detectable levels of glyphosate in their blood.
The Appeals Court for the 11th Circuit ruled Bayer and Monsanto can not use federal preemption to avoid a Roundup lawsuit it had already settled.
A new CDC study found glyphosate, Roundup's active ingredient, in the urine of 80% of people in the U.S.
An environmental group says European regulators ignored clear evidence of glyphosate cancer risks during a recent Roundup safety assessment.